Literature DB >> 27497142

Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population.

Fumiaki Matsubara1, Yoshio Nagai2, Hidekazu Tsukiyama1, Hiroyuki Shimizu3, Eigoro Yamanouchi3, Teruaki Iwamoto3, Yukiyoshi Sada4, Hiroyuki Kato4, Akio Ohta4, Yasushi Tanaka4.   

Abstract

AIMS: To determine the threshold intrahepatic lipid (IHL) content separating metabolically normal from abnormal in a Japanese population based on proton magnetic resonance spectroscopy ((1)H-MRS).
METHODS: A total of 305 Japanese subjects aged 20-69years were investigated. The subjects underwent general examination, blood tests, and (1)H-MRS of the liver after an overnight fast. They completed a questionnaire about daily drinking habits and their daily alcohol intake was calculated.
RESULTS: The median IHL content was 4.7% in men and 1.7% in women, and it increased along with the number of features of metabolic syndrome (MetS). The optimum IHL cut-off value for separating normal subjects from those with at least one feature of MetS was 6.5% in men (AUC of ROC: 0.727, 95%-CI: 0.649-0.804) and 1.8% in women (0.765, 0.685-0.844). Alcohol intake was not correlated with the IHL content according to multiple logistic regression analysis.
CONCLUSION: This study demonstrated a close association of IHL with features of MetS and identified IHL content cut-off values for metabolic normality in Japanese subjects.
Copyright © 2016 The Author(s). Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Intrahepatic lipid content; Metabolic syndrome; Nonalcoholic fatty liver disease; Proton magnetic resonance spectroscopy

Mesh:

Substances:

Year:  2016        PMID: 27497142     DOI: 10.1016/j.diabres.2016.07.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series.

Authors:  Satoshi Ishii; Yoshio Nagai; Yukiyoshi Sada; Hisashi Fukuda; Yuta Nakamura; Ren Matsuba; Tomoko Nakagawa; Hiroyuki Kato; Yasushi Tanaka
Journal:  J Clin Med Res       Date:  2019-02-13

2.  Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes.

Authors:  Satoshi Ishii; Yoshio Nagai; Hiroyuki Kato; Hisashi Fukuda; Yasushi Tanaka
Journal:  J Clin Med Res       Date:  2020-02-01

3.  Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption.

Authors:  Melynda S Coker; Kaylee R Ladd; Jimin Kim; Carl J Murphy; Ryan DeCort; Bradley R Newcomer; Robert R Wolfe; Robert H Coker
Journal:  Nutrients       Date:  2020-01-19       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.